Cencora, Inc.
As of Oct 22, 2026 close
- Market cap
- $65.65B
- P/E (TTM)
- 25.01
- Forward P/E
- 18.14
- Dividend yield
- 0.71%
- 52-week range
- $244.82$377.54
- Volume (live)
- -
- Avg. volume (3M)
- 1.23M
Cencora (COR) Stock Price & Financial Analysis
Cencora Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $337.11 - $344.43 |
|---|---|
| 52-Week High | $377.54 |
| 52-Week Low | $244.82 |
| Open | $344.43 |
| Volume (last close) | 1.18M |
| Average Volume (3M) | 1.23M |
| Revenue (TTM) | 332.77B |
|---|---|
| Net Income (TTM) | 2.62B |
| Free Cash Flow (TTM) | 4.06B |
| EPS (TTM) | $13.49 |
| Profit Margin | 0.79% |
| Operating Margin | 1.36% |
| Return on Equity (ROE) | 81.03% |
| Debt to Equity | 3.62 |
| Annual Dividend | $2.40 |
|---|---|
| Dividend Yield | 0.71% |
| Payout Ratio | 17.80% |
| Last Dividend Ex-Date | Aug 14, 2026 |
| Market Cap | 65.65B |
|---|---|
| Shares Outstanding | 193.94M |
| P/E Ratio (TTM) | 25.01 |
| Forward P/E | 18.14 |
| Price to Sales (P/S) | 0.20 |
| Price to Book (P/B) | 20.27 |
| EV/EBITDA | 14.26 |
| 50-Day MA | $321.00 |
|---|---|
| 200-Day MA | $317.52 |
| 1-Year Change | +3.02% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Cencora at a Glance
As of the Oct 22, 2026 close, Cencora (COR) has a market capitalization of $65.65B. The stock trades at 25.0× trailing earnings, 18.1× forward earnings and 0.2× sales. Over the trailing twelve months it earned $2.62B on revenue of $332.77B (a 0.8% profit margin) and generated $4.06B of free cash flow. Revenue grew 5.1% year over year.
As of its latest reported balance sheet, it holds $2.82B in cash and securities against $11.72B of debt, a net debt position of $8.91B.
Cencora pays a quarterly dividend totaling $2.40 per share a year, a 0.71% yield at the Oct 22, 2026 close, with a 18% payout ratio and 4 consecutive years of dividend increases.
The share price is up 3.0% over the past year. At $338.48 (the Oct 22, 2026 close) it sits within its 52-week range of $244.82 to $377.54, above its 200-day moving average of $317.52.
Based on 14 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $368.25, 8.8% above the Oct 22, 2026 close.
Frequently Asked Questions About Cencora
What is the current stock price for COR?
As of the Oct 22, 2026 close, COR stock trades at $338.48. The 52-week range is $244.82–$377.54, with a day range of $337.11–$344.43.
What is the P/E ratio for COR?
As of the Oct 22, 2026 close, Cencora's trailing twelve-month (TTM) P/E ratio is 25.0, meaning investors pay $25.0 for every $1 of annual earnings. The forward P/E is 18.1, reflecting analyst expectations for future earnings. Cencora operates in the Healthcare sector.
Does COR pay dividends?
Yes, Cencora pays a 0.71% annual dividend yield as of the Oct 22, 2026 close ($2.40 per share a year). The trailing twelve-month payout ratio is 17.8%. The most recent ex-dividend date was August 14, 2026.
What do analysts recommend for COR?
Based on ratings from 14 professional analysts over the last 90 days, the consensus for COR is Buy. The average 12-month price target is $368.25, a 8.8% upside from the Oct 22, 2026 close of $338.48.
What is the market cap of COR?
As of the Oct 22, 2026 close, Cencora's market capitalization is $65.65B, classifying it as a large-cap company. Cencora operates in the Healthcare sector within the Medical Distribution industry.